These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 34663921)
1. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Ouspenskaia T; Law T; Clauser KR; Klaeger S; Sarkizova S; Aguet F; Li B; Christian E; Knisbacher BA; Le PM; Hartigan CR; Keshishian H; Apffel A; Oliveira G; Zhang W; Chen S; Chow YT; Ji Z; Jungreis I; Shukla SA; Justesen S; Bachireddy P; Kellis M; Getz G; Hacohen N; Keskin DB; Carr SA; Wu CJ; Regev A Nat Biotechnol; 2022 Feb; 40(2):209-217. PubMed ID: 34663921 [TBL] [Abstract][Full Text] [Related]
2. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1). Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486 [TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma. Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887 [TBL] [Abstract][Full Text] [Related]
4. Critical Review of Existing MHC I Immunopeptidome Isolation Methods. Kuznetsov A; Voronina A; Govorun V; Arapidi G Molecules; 2020 Nov; 25(22):. PubMed ID: 33228004 [TBL] [Abstract][Full Text] [Related]
5. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy. Zhang X; Qi Y; Zhang Q; Liu W Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254 [TBL] [Abstract][Full Text] [Related]
6. Most non-canonical proteins uniquely populate the proteome or immunopeptidome. Ruiz Cuevas MV; Hardy MP; Hollý J; Bonneil É; Durette C; Courcelles M; Lanoix J; Côté C; Staudt LM; Lemieux S; Thibault P; Perreault C; Yewdell JW Cell Rep; 2021 Mar; 34(10):108815. PubMed ID: 33691108 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes. Gloger A; Ritz D; Fugmann T; Neri D Cancer Immunol Immunother; 2016 Nov; 65(11):1377-1393. PubMed ID: 27600516 [TBL] [Abstract][Full Text] [Related]
8. MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia. Cai Y; Li D; Lv D; Yu J; Ma Y; Jiang T; Ding N; Liu Z; Li Y; Xu J Sci Data; 2024 Aug; 11(1):831. PubMed ID: 39090129 [TBL] [Abstract][Full Text] [Related]
9. A tissue-based draft map of the murine MHC class I immunopeptidome. Schuster H; Shao W; Weiss T; Pedrioli PGA; Roth P; Weller M; Campbell DS; Deutsch EW; Moritz RL; Planz O; Rammensee HG; Aebersold R; Caron E Sci Data; 2018 Aug; 5():180157. PubMed ID: 30084848 [TBL] [Abstract][Full Text] [Related]
10. Identification of the Cryptic HLA-I Immunopeptidome. Erhard F; Dölken L; Schilling B; Schlosser A Cancer Immunol Res; 2020 Aug; 8(8):1018-1026. PubMed ID: 32561536 [TBL] [Abstract][Full Text] [Related]
12. Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design. Jappe EC; Garde C; Ramarathinam SH; Passantino E; Illing PT; Mifsud NA; Trolle T; Kringelum JV; Croft NP; Purcell AW Nat Commun; 2020 Dec; 11(1):6305. PubMed ID: 33298915 [TBL] [Abstract][Full Text] [Related]
13. MHC Class I Immunopeptidome: Past, Present, and Future. Yewdell JW Mol Cell Proteomics; 2022 Jul; 21(7):100230. PubMed ID: 35395404 [TBL] [Abstract][Full Text] [Related]
14. An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool. Verkerk T; Koomen SJI; Fuchs KJ; Griffioen M; Spaapen RM Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2119736119. PubMed ID: 35858315 [TBL] [Abstract][Full Text] [Related]
15. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N Elife; 2020 Apr; 9():. PubMed ID: 32314731 [TBL] [Abstract][Full Text] [Related]
16. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models. Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383 [TBL] [Abstract][Full Text] [Related]
17. Exploration of peptides bound to MHC class I molecules in melanoma. Pritchard AL; Hastie ML; Neller M; Gorman JJ; Schmidt CW; Hayward NK Pigment Cell Melanoma Res; 2015 May; 28(3):281-94. PubMed ID: 25645385 [TBL] [Abstract][Full Text] [Related]
18. Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Bourne CM; Mun SS; Dao T; Aretz ZEH; Molvi Z; Gejman RS; Daman A; Takata K; Steidl C; Klatt MG; Scheinberg DA Blood Adv; 2022 Jul; 6(14):4107-4121. PubMed ID: 35561310 [TBL] [Abstract][Full Text] [Related]
19. Tools to define the melanoma-associated immunopeptidome. Bräunlein E; Krackhardt AM Immunology; 2017 Dec; 152(4):536-544. PubMed ID: 28755382 [TBL] [Abstract][Full Text] [Related]
20. An Integrated Approach for Discovering Noncanonical MHC-I Peptides Encoded by Small Open Reading Frames. Chen L; Zhang Y; Yang Y; Yang Y; Li H; Dong X; Wang H; Xie Z; Zhao Q J Am Soc Mass Spectrom; 2021 Sep; 32(9):2346-2357. PubMed ID: 34260243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]